Nkarta Reports Second Quarter 2021 Financial Results and Business Progress
Initial data from NKX101 clinical trial expected by end of 2021 NKX019 patient dosing expected…
Month: August 2021
Adicet Reports Second Quarter 2021 Financial Results and Provides Business Updates
On track to report top-line interim data from ADI-001 Phase 1 study in Non-Hodgkin’s Lymphoma…
Eledon Pharmaceuticals Reports Second Quarter 2021 Operating and Financial Results
Received approval from Health Canada to initiate a clinical trial of AT-1501 in kidney transplantation;…
CorMedix Inc. Reports Second Quarter and Six Month 2021 Financial Results and Provides Business Update
Conference Call Scheduled for Today at 4:30 p.m. Eastern Time BERKELEY HEIGHTS, N.J., Aug. 12,…
Myovant Sciences Appoints Uneek Mehra as Chief Financial and Business Officer
BASEL, Switzerland, Aug. 12, 2021 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE: MYOV), a healthcare company…
Brickell Biotech Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Final patient has completed the Phase 3 pivotal Cardigan I study; Enrollment completed in Phase…
Progenity Provides Corporate Update and Reports Second Quarter 2021 Financial Results
Announced successful completion of the validation study PRO-104 for the Preecludia™ rule out test for preeclampsia…
TFF Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update
Additional Data Readouts and Initiation of Pivotal Trials for Inhaled Tacrolimus and Voriconazole Programs Expected…
Tempest Reports Second Quarter 2021 Financial Results and Provides Corporate Highlights
Closed merger transaction resulting in public listing (TPST) Closed $30M PIPE, extending runway into Q1’23…
Seer Bio Partners with Enlight Medical to Commercialize the Proteograph™ Product Suite in China
REDWOOD CITY, Calif. and BEIJING, Aug. 12, 2021 (GLOBE NEWSWIRE) — Seer Inc. (NASDAQ: SEER),…
Capricor Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update
CAP-1002 – Capricor’s Cell Therapy Program for Duchenne Muscular Dystrophy -Phase III Trial Protocol Submitted…
Greenrose Acquisition Corp. Announces Extension of Time to Consummate Business Combinations
AMITYVILLE, N.Y., Aug. 12, 2021 (GLOBE NEWSWIRE) — Greenrose Acquisition Corp. (OTC: GNRSU, GNRS, GNRSW)…
Salarius Pharmaceuticals to Present at the Virtual Diamond Equity Research Emerging Growth Invitational
HOUSTON, Aug. 12, 2021 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical…
InMed Pharmaceuticals to Present at the H.C. Wainwright Ophthalmology Virtual Conference
VANCOUVER, British Columbia, Aug. 12, 2021 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the…
Tarsus Pharmaceuticals, Inc. Appoints Pharmaceutical and Healthcare Industry Leader Rosemary A. Crane to Board of Directors
Ms. Crane brings over 30 years of experience in executive leadership, commercialization, and business development…
Sunshine Biopharma’s Coronavirus Treatment Anticipated to be Effective Against Delta and the Other Variants of Concern
MONTREAL, Aug. 12, 2021 (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (OTC Pink: “SBFM”), a pharmaceutical…
Zealand Pharma Launches ZEGALOGUE® (dasiglucagon) Injection and Advances Pipeline Programs Across Multiple Therapeutic Areas
Company annoucement – No. 50 / 2021 Interim report for H1 2021 Zealand Pharma Launches…
Last Patient Last Visit Completed in Innovation Pharmaceuticals’ Phase 2 Clinical Trial of Brilacidin for COVID-19; Trial Database Undergoing Review in Preparation for Database Lock
WAKEFIELD, Mass., Aug. 12, 2021 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical…
OliX Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for Investigational Hair Loss Therapeutic, OLX104C
SUWON, Republic of Korea, Aug. 12, 2021 (GLOBE NEWSWIRE) — OliX Pharmaceuticals, Inc. (KOSDAQ: 226950),…
atai Launches Revixia Life Sciences to Develop Salvinorin A for a Variety of Mental Health Conditions
BERLIN, Aug. 12, 2021 (GLOBE NEWSWIRE) — atai Life Sciences (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming…